A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants
Status:
RECRUITING
Trial end date:
2025-02-27
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and tolerability of H021 tablets following oral administration of single and multiple ascending doses in healthy participants.